A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

NCT04152083 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

H. Lundbeck A/S

Collaborators

[object Object]